| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥376.0B | ¥348.2B | +8.0% |
| Operating Income | ¥19.1B | ¥9.5B | +101.4% |
| Ordinary Income | ¥21.8B | ¥10.0B | +118.3% |
| Net Income | ¥18.5B | ¥8.1B | +127.6% |
| ROE | 5.9% | 2.7% | - |
FY2025 Q3 cumulative results show revenue of 376.0B yen (YoY +8.0%), operating income of 19.1B yen (YoY +101.4%), ordinary income of 21.8B yen (YoY +118.3%), and net income of 18.5B yen (YoY +127.6%). The dramatic profit expansion was driven by improved gross profit margins and controlled selling, general and administrative expenses, coupled with non-operating gains including dividend income of 2.18B yen and extraordinary gains from investment securities sales of 3.76B yen and fixed asset sales of 1.66B yen. Basic earnings per share improved to 145.37 yen from 60.98 yen in the prior year period. While the company achieved strong operating leverage with SG&A expenses growing at a slower pace than revenue, the balance sheet shows mixed signals with increased short-term liabilities including short-term borrowings rising 39.2% to 34.8B yen and accounts payable up 28.1% to 125.5B yen. Working capital efficiency metrics show deterioration with days sales outstanding at 113 days and days inventory outstanding at 120 days. The equity ratio stands at 56.1% with total assets of 555.0B yen and equity of 311.6B yen, maintaining adequate financial stability despite elevated short-term debt ratios.
Revenue growth of 8.0% to 376.0B yen was achieved through expansion across all major operating segments. The Plastic Chemicals Division generated sales of 178.2B yen representing the largest revenue contribution, while the Ink Division reached 139.4B yen and the Plastic Products Division contributed 57.9B yen. The YoY revenue increase reflects volume growth and favorable market conditions across the product portfolio. On the profit side, operating income more than doubled to 19.1B yen driven by gross profit improvement to 63.6B yen while SG&A expenses increased modestly to 44.5B yen, demonstrating effective cost management and operating leverage. The operating margin expanded to 5.1% from 2.7% YoY, indicating improved pricing power or cost structure optimization. Non-operating income contributed 3.3B yen primarily from dividend income of 2.18B yen, while extraordinary gains of 5.4B yen including investment securities sales of 3.76B yen and fixed asset sales of 1.66B yen significantly boosted net income. The gap between operating income of 19.1B yen and net income of 18.5B yen reflects these non-recurring gains offsetting corporate tax of 7.7B yen. The presence of substantial extraordinary items indicates that approximately 29% of pre-tax profit originated from non-operating and non-recurring sources, warranting attention to earnings quality. This represents a revenue up and profit up pattern, with profit growth substantially outpacing revenue growth due to both operational improvements and non-recurring factors.
The Plastic Chemicals Division is the core business generating sales of 178.2B yen with operating income of 672 million yen, representing an operating margin of 3.8%. The Ink Division produced sales of 139.4B yen with operating income of 844 million yen, achieving a 6.1% operating margin that exceeds the company average and indicates stronger profitability characteristics. The Plastic Products Division contributed sales of 57.9B yen with operating income of 429 million yen, yielding a 7.4% operating margin that represents the highest profitability among segments. The Real Estate Leasing Division generated minimal sales of 68 million yen with operating income of 39 million yen, representing a very high 57.4% margin typical of rental income businesses but with immaterial scale. Material margin differences exist across segments, with the Plastic Products Division demonstrating the strongest unit economics at 7.4% margin, while the largest revenue generator Plastic Chemicals Division operates at 3.8% margin, suggesting different competitive dynamics and value propositions across the business portfolio.
[Profitability] ROE of 5.9% improved from lower prior year levels, though remains modest relative to the company's cost of capital. Operating margin reached 5.1%, expanding from 2.7% YoY and representing a 2.4 percentage point improvement driven by gross margin enhancement and SG&A leverage. Net profit margin of 4.9% reflects the combination of improved operating performance and non-recurring gains. ROIC of 4.2% indicates capital efficiency below optimal levels and warrants attention to invested capital management. [Cash Quality] Cash and cash equivalents stood at 196.9B yen with short-term debt coverage of 5.66 times, indicating adequate liquidity buffers. Working capital metrics show deterioration with DSO at 113 days and DIO at 120 days, extending the cash conversion cycle. [Investment Efficiency] Asset turnover of 0.677 indicates the company generates 67.7 yen of revenue per 100 yen of assets employed. Inventory turnover at 120 days exceeds manufacturing industry norms and signals potential efficiency improvement opportunities. [Financial Health] Equity ratio of 56.1% provides a solid capital foundation. Current ratio of 167.0% and quick ratio of 141.5% demonstrate healthy short-term liquidity. Debt-to-equity ratio of 0.18 reflects conservative leverage with total interest-bearing debt of 55.8B yen. However, short-term liabilities represent 62.3% of total liabilities, elevating refinancing risk despite overall moderate leverage levels. Interest coverage of 47.7 times indicates comfortable debt servicing capacity.
Cash and deposits increased 19.6B yen YoY to 196.9B yen, with operating profit growth contributing to cash accumulation despite the expansion of working capital. The increase in accounts payable of 27.5B yen YoY to 125.5B yen reflects effective utilization of supplier credit as a financing source, while electronically recorded obligations also increased, supporting liquidity through trade credit optimization. Short-term borrowings rose 9.8B yen to 34.8B yen, supplementing working capital needs amid business expansion. Long-term borrowings decreased 8.1B yen to 21.0B yen, indicating debt repayment or refinancing into shorter maturities. Inventories increased 3.5B yen to 50.9B yen, consistent with revenue growth but contributing to extended DIO. Trade receivables and electronically recorded receivables combined show an increase supporting the DSO extension to 113 days. Cash coverage of short-term liabilities stands at 1.28 times, providing reasonable liquidity cushion. The balance sheet changes suggest operating profit generation supported cash accumulation, though working capital expansion and increased short-term debt utilization indicate growing operational funding requirements that merit monitoring for refinancing and efficiency improvement opportunities.
Ordinary income of 21.8B yen versus operating income of 19.1B yen shows non-operating net contribution of approximately 2.7B yen, comprising primarily dividend income of 2.18B yen alongside modest financial income and foreign exchange gains. Extraordinary gains of 5.4B yen including investment securities sales of 3.76B yen and fixed asset sales of 1.66B yen represent non-recurring items that boosted pre-tax profit by approximately 21%. Non-operating and extraordinary income combined represent 1.4% and 1.4% of revenue respectively, indicating meaningful profit contribution from non-core sources. The composition of earnings reveals that while operating profit doubled YoY reflecting genuine operational improvement, approximately 37% of pre-tax profit originated from non-operating and non-recurring sources, raising questions about earnings persistence. Operating cash flow disclosure is limited in the quarterly report, preventing direct assessment of cash conversion quality, though the extension of DSO and DIO suggests potential working capital drag on cash generation. The substantial non-recurring gains warrant adjustment when evaluating normalized earnings power and future profit sustainability.
Full-year guidance projects revenue of 496.0B yen, operating income of 21.0B yen, ordinary income of 23.5B yen, and net income of 19.5B yen. Q3 cumulative progress against full-year targets shows revenue at 75.8%, operating income at 91.0%, ordinary income at 92.8%, and net income at 94.9%. Operating income and net income are tracking significantly ahead of the standard 75% progress rate expected at Q3, indicating strong year-to-date performance with meaningful front-loading of profits. The revenue progress rate of 75.8% aligns closely with the standard progression, suggesting Q4 revenue targets remain achievable. The elevated profit progress rates reflect both the YoY improvement in operating margins and the contribution of non-recurring gains in the first nine months. Management's full-year guidance implies Q4 operating income of approximately 1.9B yen and net income of 0.5B yen, representing a sequential slowdown from the Q3 run rate that may reflect anticipated seasonal patterns, absence of extraordinary gains in Q4, or conservative planning. The forecast assumptions were not disclosed in available materials, limiting visibility into management's outlook for market conditions and cost trends in the final quarter.
The company declared an interim dividend of 60 yen per share and forecasts a year-end dividend of 130 yen per share. However, the full-year guidance indicates a dividend per share of 37 yen, creating inconsistency in the disclosed information that requires clarification. Based on the interim and forecast year-end dividends totaling 190 yen per share against net income per share of 145.37 yen for the nine-month period, the implied payout ratio would exceed 130%. Against the full-year forecast net income per share of 153.66 yen, a total annual dividend of 190 yen would represent a payout ratio of 124%. This elevated payout ratio substantially exceeds typical sustainable levels and raises questions about dividend policy sustainability, particularly given the contribution of non-recurring gains to current period earnings. No share buyback activities were disclosed in the available materials. The high payout ratio suggests limited retained earnings for reinvestment or balance sheet strengthening, and investors should seek management clarification on dividend policy rationale, sustainability assessment, and whether the current level reflects special distributions related to asset sale gains.
Raw material price volatility and supply chain disruption risk pose significant exposure for the ink and chemicals manufacturing operations, as input cost fluctuations directly impact gross margins with potential lag in pricing adjustment to customers. Customer concentration and demand cyclicality risk stems from the company's exposure to specific end markets where economic downturns or customer industry challenges could rapidly impact order volumes and revenue stability, amplified by the extended DSO of 113 days indicating significant trade credit exposure. Working capital efficiency deterioration and refinancing risk emerges from the combination of extended cash conversion cycle with DSO at 113 days and DIO at 120 days alongside elevated short-term liabilities at 62.3% of total liabilities including 34.8B yen in short-term borrowings, creating potential liquidity pressure if operating performance weakens or refinancing conditions tighten.
[Industry Position] (Reference - Proprietary Analysis) The company's operating margin of 5.1% positions below the manufacturing industry median of 8.7%, indicating room for improvement in operational efficiency or pricing power relative to peers. Net profit margin of 4.9% also trails the industry median of 6.4%, reflecting the lower operating profitability partially offset by non-operating income contributions. ROE of 5.9% aligns closely with the industry median of 5.2%, placing the company near the middle of the peer distribution for equity returns. The equity ratio of 56.1% falls modestly below the industry median of 63.8%, suggesting slightly higher leverage utilization though still maintaining conservative capital structure. Asset turnover of 0.677 exceeds the industry median of 0.58, indicating superior asset utilization efficiency in generating revenue. ROIC of 4.2% tracks near the industry median of 6.0%, confirming capital efficiency challenges are somewhat industry-wide though the company's position warrants improvement. Working capital metrics show DSO of 113 days and DIO of 120 days both exceeding industry medians of 83 days and 109 days respectively, highlighting material efficiency disadvantage in cash conversion cycle management. Revenue growth of 8.0% substantially outpaces the industry median of 2.8%, demonstrating strong top-line momentum relative to peers. The current ratio of 167.0% positions well below the industry median of 283.0%, indicating tighter liquidity management though still adequate coverage. Overall, the company demonstrates strong revenue growth and asset turnover but lags in profitability margins and working capital efficiency compared to manufacturing industry peers. (Industry: Manufacturing, N=100 companies, Comparison: FY2025-Q3, Source: Proprietary analysis)
The company achieved substantial profit expansion with operating income doubling YoY through improved gross margins and cost leverage, though profitability margins remain below manufacturing industry benchmarks, indicating further operational improvement potential. Non-recurring gains from investment securities and fixed asset sales contributed approximately 21% of pre-tax profit, requiring adjustment to assess normalized earnings power and future profit sustainability absent these one-time items. Working capital efficiency deterioration with DSO extending to 113 days and DIO to 120 days alongside short-term liabilities comprising 62.3% of total liabilities creates refinancing risk and cash flow pressure that warrant management focus on collection, inventory optimization, and debt maturity profile management.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.